Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.

Biotechnology

Education

Dewpoint Therapeutics

Ameet Nathwani

Lili Zhang

Michael Wagner

Étienne Dumoulin

Suguna Rachakonda

Stephanie Robertson

Thomas Durand-Réville

Nino Jeena

Weiwei Rao

Dean Mula

Geoff Stamper

Isaac Klein

Lori Escobedo

Elina Sinisalo

Aravind Subramanian

Kelly Clark

Michael Fenn

Denise Schultz

The Advisory Team at Dewpoint Therapeutics provides expert guidance and strategic insights to support the company's mission in applying biomolecular condensates to drug discovery. Comprising seasoned professionals and scientific advisors, the team advises on research direction, potential therapeutic targets, and innovative approaches to address conditions regulated by or arising from condensate dysfunction, including cancer, neurodegeneration, and metabolic diseases.

Advisory Team

Science and Research

Leadership Team

Advisory Team

About

Team members

Other teams at Dewpoint Therapeutics

Science and Research

Leadership Team